## Abstract Protein kinase C (PKC) isozymes are widely recognized as targets for anticancer therapy, and recent investigations demonstrated that PKC activators are potential therapeutic candidates for Alzheimer's disease and acquired immune deficiency syndrome. However, concerns exist about their t
Relevance of Atypical Protein Kinase C Isotypes to the Drug Discovery Process
β Scribed by Marcel Jenny; Oliver A. Wrulich; Wolfgang Schwaiger; Florian Ueberall
- Book ID
- 101822856
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 358 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1439-4227
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In an effort to understand the role of protein kinase C (PKC) in nerve growth factor-induced differentiation, we studied the expression of PKC using isoformspecific antibodies. Western blot analysis on whole cell lysates showed that a,b \ \ ,g,d,e,z, Δ±/l and m were expressed in PC12 cells, except fo
Derivatives of camptothecins, topoisomerase I inhibitors and 7-hydroxystaurosporine (UCN-01), a protein kinase C (PKC) inhibitor and cell cycle checkpoint abrogator, are promising anticancer drugs. We characterized the apoptotic response to camptothecin and UCN-01 for the 8 human breast carcinoma ce